Muscle Strength in Children and Adolescents With Haemophilia on Prophylaxis: An Age-Adjusted Dynamometric Study

Dimitrios Syrengelas1, George Triantafyllou2, Aikaterini Michalopoulou3

  • 1Department of Pediatric Physical Therapy, "Aghia Sophia" Children's Hospital, Athens, Greece.

Insights

Children with haemophilia (CwH) show reduced knee strength, especially in the non-dominant leg, even with prophylaxis. Early physiotherapy and strength monitoring are crucial for these children.

Area of Science:

  • Paediatric Orthopaedics
  • Sports Medicine
  • Haematology

Background:

  • Children with haemophilia (CwH) are susceptible to decreased muscle strength from joint bleeds and disuse.
  • Limited data exists on muscle strength in contemporary paediatric haemophilia populations receiving prophylaxis.

Purpose of the Study:

  • To assess the impact of haemophilia on muscle strength in children and adolescents.
  • To adjust for age when evaluating strength differences between children with haemophilia and healthy controls.

Main Methods:

  • Isometric dynamometry was used to measure elbow and knee flexion/extension strength in 34 boys with haemophilia and 25 healthy controls.
  • General linear models (GLM) analyzed strength variables, with age as a covariate and group as a factor.
  • Regression models further investigated age-adjusted strength differences.

Main Results:

  • Muscle strength showed a strong correlation with age in both groups.
  • GLM revealed significant effects of both age and group on strength.
  • Children with haemophilia exhibited significantly lower isometric strength in left-knee flexion and extension compared to controls, with age-adjusted deficits of -17.9 N and -26.6 N, respectively.

Conclusions:

  • Children with haemophilia demonstrate reduced isometric knee strength, particularly in the non-dominant limb, despite prophylactic treatment.
  • Individualized physiotherapy and consistent strength monitoring are recommended for early intervention in CwH.
  • Strength deficits tend to decrease with increasing age.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Exercise and Muscle Performance01:27

Exercise and Muscle Performance

Exercise induces a range of adaptations in muscle tissue, depending on the type and duration of activity. Such physical training can be broadly categorized into two types: endurance exercises and resistance exercises.
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
6.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354